UNSPSC 85733504: Revision of intraluminal device in ureter, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of intraluminal device in ureter, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TW94DZ

UNSPSC 85733504 Revision of intraluminal device in ureter, percutaneous endoscopic approach, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's medical device classification does not match the work actually being solicited under it, which spans occupational health surveillance, disability medical evaluation services, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing, and youth detention healthcare — none of which involve urological device revision. State and local bodies issuing under this code include county health systems, state transportation departments, county governments, municipal retirement offices, and juvenile probation departments. The issuing-body mix reflects fragmented health and human services procurement rather than a coherent medical device or procedure category.

Recent solicitations active as of late August and September 2026 include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026, $750,000 over five years), the Washington State Department of Transportation's RFP for occupational medical surveillance services across 14 ferry system locations (due October 9, 2026), the City of Long Beach's RFP for a surgical carve-out benefit program serving 3,800 employees and retirees (due October 7, 2026, go-live targeted April 1, 2027), and the County of Santa Clara Health System's non-exclusive vendor qualification for temporary health professional staffing across multiple ancillary clinical categories (due October 7, 2026). These opportunities span Arizona, California, and Washington. The code's tagging appears to be a data-quality issue rather than a signal of genuine procurement demand in the urological device space.